Sarah Condella - 27 Feb 2026 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Signature
/s/ Sarah Condella by Mark Busch, attorney-in- fact
Issuer symbol
EXAS
Transactions as of
27 Feb 2026
Net transactions value
-$178,149
Form type
4
Filing time
03 Mar 2026, 19:16:13 UTC
Previous filing
27 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Condella Sarah EVP, Human Resources C/O EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON /s/ Sarah Condella by Mark Busch, attorney-in- fact 03 Mar 2026 0001839989

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $19,617 +3,900 +3% $5.03 133,034 27 Feb 2026 Direct
transaction EXAS Common Stock Tax liability $197,766 -1,913 -1.4% $103.38 131,121 27 Feb 2026 Direct F1, F2
holding EXAS Common Stock 6,368 27 Feb 2026 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Stock Options (Right to Buy) Options Exercise $0 -3,900 -100% $0.000000 0 27 Feb 2026 Common Stock 3,900 $5.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the exercise of certain stock options.
F2 In addition to the shares of Common Stock reported on this Form 4, which total 137,489 shares, Ms. Condella also holds, in the aggregate, an additional 71,243 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F3 These options vested and became exercisable in full on February 28, 2020.